Update on the safety information for medicinal products containing tozinameran (tozinameran [COVID-19 mRNA vaccine – Comirnaty]) , adopted by the PRAC committee during the review of signals discussed at the meeting of 24-27 October 2022
08.12.2022
1205
Having considered all available evidence, including spontaneous reports from EudraVigilance, data from national reviews, and observational studies provided by the registration certificate holder (RCH),…
Read more